Nourica is a European MedTech startup founded in 2022, based in Poland. The company's mission is to develop innovative devices for non-invasive health biomarker testing from human sweat. Their slogan, "Non-invasive health biomarkers diagnostics from human sweat," emphasizes their focus on non-invasive diagnostic solutions.
Utilizing state-of-the-art spectroscopic technology, Nourica has designed diagnostic devices that can extract and analyze biomarkers from human sweat. This approach provides a convenient and reliable solution for disease screening, health monitoring, and dietary adjustments, addressing significant needs within the Health Care industry.
The startup recently secured a $250.00K pre-seed round investment on 20 December 2022 from Scanderia Venture, showcasing early investor confidence in their innovative approach to health diagnostics. With this support, Nourica is well-positioned to advance their technology and expand their market presence, potentially disrupting traditional health diagnostic methods and making significant contributions to the MedTech industry.